AKYA — Akoya Biosciences Balance Sheet
0.000.00%
Last trade - 00:00HealthcareAdventurousSmall CapSucker Stock
- $210.46m
- $214.82m
- $74.86m
- 38
- 17
- 38
- 20
Annual balance sheet for Akoya Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Cash and Equivalents | ||||
| Short Term Investments | ||||
| Cash and Short Term Investments | 21.7 | 17 | 113 | 81.2 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 13.2 | 6.47 | 9.44 | 9.73 |
| Total Inventory | ||||
| Prepaid Expenses | ||||
| Total Current Assets | 40.9 | 28.7 | 141 | 112 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 5.46 | 7.02 | 10 | 24.5 |
| Net Goodwill | ||||
| Net Intangible Assets | ||||
| Other Long Term Assets | ||||
| Total Assets | 89.4 | 77.7 | 191 | 176 |
| Accounts Payable | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 21.2 | 17.2 | 27.7 | 37.1 |
| Long Term Debt | ||||
| Capital Lease Obligations | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Deferred Income Tax | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 55.2 | 59.6 | 69.6 | 117 |
| Redeemable Preferred Stock | ||||
| Non Redeemable Preferred Stock | ||||
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Other Equity | ||||
| Total Equity | 34.2 | 18.1 | 121 | 58.6 |
| Total Liabilities & Shareholders' Equity | 89.4 | 77.7 | 191 | 176 |
| Total Common Shares Outstanding |